Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 4/20 | 0.62 |
| ▸ | DPP4 | P27487 | 1/20 | 0.53 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.53 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.52 |
| ▸ | GRM8 | O00222 | 1/20 | 0.52 |
| ▸ | GRM6 | O15303 | 1/20 | 0.52 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.52 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.52 |
| ▸ | GSR | P00390 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.52 |
| ▸ | GRM5 | P41594 | 1/20 | 0.52 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.52 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.52 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.52 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.52 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.52 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15420942 | 1.00 | FOLH1 (0.62) | FOLH1DPP4DPP8DPP9PTGS1 | |
| SCHEMBL210006 | 1.00 | FOLH1 (0.62) | FOLH1DPP4DPP8DPP9PTGS1 | |
| SCHEMBL15420941 | 1.00 | FOLH1 (0.62) | FOLH1DPP4DPP8DPP9PTGS1 | |
| SCHEMBL210315 | 1.00 | FOLH1 (0.62) | FOLH1DPP4DPP8DPP9PTGS1 | |
| SCHEMBL27611010 | 0.97 | FOLH1 (0.58) | FOLH1DPP4DPP8DPP9PTGS1 | |
| SCHEMBL27611015 | 0.97 | FOLH1 (0.58) | FOLH1DPP4DPP8DPP9PTGS1 | |
| SCHEMBL16770243 | 0.97 | FOLH1 (0.58) | FOLH1DPP4DPP8DPP9PTGS1 | |
| Glycine SCHEMBL343653 | 0.95 | FOLH1 (0.57) | FOLH1DPP4DPP8DPP9PTGS1 | |
| SCHEMBL9760353 | 0.95 | FOLH1 (0.61) | FOLH1DPP4DPP8DPP9PTGS1 | |
| SCHEMBL30382437 | 0.95 | FOLH1 (0.61) | FOLH1DPP4DPP8DPP9PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 952 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116769738-B | Glutamyl cysteine synthetase mutant and application thereof in glutathione synthesis | 江苏集萃工业生物技术研究所有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20250334558-A1 | TOTAL HYDROGEN SULFIDE QUANTIFICATION | CLEVELAND CLINIC FOUND (US) | 2025-10-30 | — | — | US | claimed |
| EP-4622471-A1 | BOVINE COLOSTRUM-DERIVED NUTRITIONAL SUPPLEMENTS AND USES THEREOF | University of Maryland, Baltimore (US) | 2025-10-01 | — | — | EP | claimed |
| EP-4608966-A1 | YEAST COMPOSITIONS HAVING ANTIOXIDANT PROPERTIES | DANSTAR FERMENT AG (CH) | 2025-09-03 | — | — | EP | claimed |
| US-20250269072-A1 | PROCESSES FOR PREPARING RADIOLABELLED CONJUGATES | CENTENARY INST OF CANCER MEDICINE AND CELL BIOLOGY (AU) | 2025-08-28 | — | — | US | claimed |
| US-20250228969-A1 | GENE EDITING TO IMPROVE JOINT FUNCTION | ORTHOBIO THERAPEUTICS, INC. | 2025-07-17 | — | — | US | claimed |
| EP-4491702-A1 | BIOLOGICAL ANTIOXIDANT FOR FRUIT JUICE AND FRUIT WINE, PREPARATION METHOD THEREFOR, AND USE THEREOF | Angel Yeast Co., Ltd (CN) | 2025-01-15 | — | — | EP | claimed |
| US-20240385183-A1 | METABOLIC AND MICROBIAL BIOMARKERS FOR DETECTION OF PANCREATICOBILIARY CANCERS | NORTHWESTERN UNIVERSITY | 2024-11-21 | — | — | US | claimed |
| CN-118549609-A | Method for researching action mechanism of Nrf2/ARE signal path on resveratrol for protecting dopaminergic nerve cells | 东莞市松山湖中心医院(东莞市石龙人民医院、东莞市第三人民医院、东莞市心血管病研究所) | 2024-08-27 | — | — | CN | claimed |
| EP-4416121-A1 | PROCESSES FOR PREPARING RADIOLABELLED CONJUGATES | Centenary Institute Of Cancer Medicine And Cell Biology (AU) | 2024-08-21 | — | — | EP | claimed |
| EP-0648261-A1 | A RETROVIRAL VECTOR CAPABLE OF TRANSDUCING THE ALDEHYDE DEHYDROGENASE-1 GENE AND USES OF SAID VECTOR | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1995-04-19 | — | — | EP | claimed |
| WO-1994023015-A1 | A RETROVIRAL VECTOR CAPABLE OF TRANSDUCING THE ALDEHYDE DEHYDROGENASE-1 GENE AND USES OF SAID VECTOR | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1994-10-13 | — | — | WO | claimed |
| EP-0608217-A1 | SOLUBLE AND STABLE SOURCES OF TYROSINE, CYSTEINE AND GLUTAMINE FOR TOTAL PARENTERAL NUTRITION | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1994-08-03 | — | — | EP | claimed |
| EP-0583367-A1 | METHODS AND COMPOSITIONS FOR INHIBITING DEPOSIT FORMATION ON CONTACT LENSES | ALLERGAN, INC. (US) | 1994-02-23 | — | — | EP | claimed |
| EP-0608217-A4 | SOLUBLE AND STABLE SOURCES OF TYROSINE, CYSTEINE AND GLUTAMINE FOR TOTAL PARENTERAL NUTRITION. | RES CORP TECHNOLOGIES INC (US) | 1993-12-06 | — | — | EP | claimed |
| WO-1992021049-A1 | METHODS AND COMPOSITIONS FOR INHIBITING DEPOSIT FORMATION ON CONTACT LENSES | ALLERGAN, INC. (US) | 1992-11-26 | — | — | WO | claimed |
| WO-1991016067-A1 | SOLUBLE AND STABLE SOURCES OF TYROSINE, CYSTEINE AND GLUTAMINE FOR TOTAL PARENTERAL NUTRITION | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1991-10-31 | — | — | WO | claimed |
| CN-1049598-A | Alimentation composition | KYOWA HAKKO KOGYO KK (JP) | 1991-03-06 | — | — | CN | claimed |
| CN-1044660-A | Biologically active whey protein composition, method for producing same and use of said composition | GUSTAVO BOUNOUS (CA) | 1990-08-15 | — | — | CN | claimed |
| EP-0375852-A1 | Biologically active whey protein composition, a method for producing it and use of the composition | IMMUNOTEC RESEARCH CORPORATION LTD. (CA) | 1990-07-04 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250269072-A1 | PROCESSES FOR PREPARING RADIOLABELLED CONJUGATES | AS3MT, TP53, ANXA5 | FOLH1 252/4885DPP4 3410/4885DPP8 3592/4885 |
| US-20250228969-A1 | GENE EDITING TO IMPROVE JOINT FUNCTION | ROS1, SYVN1, ATF4 | FOLH1 2842/4885DPP4 3243/4885DPP8 2451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.